ARA290, an alternative of erythropoietin ARA290, an alternative of erythropoietin , is a synthetic peptide that has attracted significant interest in biomedical and laboratory research
Studies have observed that female mice exposed to DSIP for 5 consecutive days of every month starting at the age of 3 months till their death exhibited a 2.6-fold reduction in the development of tumors compared to parallel control groups
No serious adverse events were attributed to the compound
Since EpCAM and HGF/c-Met are involved in important signaling pathways in various cancers, the purpose of this study is to elucidate the interplay between these molecules, tumor microenvironment, and intracellular pathways
All testing is performed by independent European laboratories to ensure the highest standards of accuracy and reliability
A comprehensive panel of antibodies was utilized for Western blotting, targeting phosphorylated and total forms of ERK1/2, p38 MAPK, JNK1/2, and NF-B p65 (Ser536), with -actin serving as a loading control